Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
Open accessThe DOI matches its Crossref record; 127 of the 129 references it cites were found in a registry or an index.
Abstract
The concept of molecular mimicry was established to explain commonalities of structure which developed in response to evolutionary pressures. Most examples of molecular mimicry in medicine have involved homologies of primary protein structure which cause disease. Molecular mimicry can be expanded beyond amino acid sequence to include microRNA and proteomic effects which are either pathogenic or salutogenic (beneficial) in regard to Parkinson's disease, Alzheimer's disease, and related disorders. Viruses of animal or plant origin may mimic nucleotide sequences of microRNAs and influence protein expression. Both Parkinson's and Alzheimer's diseases involve the formation of transmissible self-propagating prion-like proteins. However, the initiating factors responsible for creation of these misfolded nucleating factors are unknown. Amyloid patterns of protein folding are highly conserved through evolution and are widely distributed in the world. Similarities of tertiary protein structure may be involved in the creation of these prion-like agents through molecular mimicry. Cross-seeding of amyloid misfolding, altered proteostasis, and oxidative stress may be induced by amyloid proteins residing in bacteria in our microbiota in the gut and in the diet. Pathways of molecular mimicry induced processes induced by bacterial amyloid in neurodegeneration may involve TLR 2/1, CD14, and NFκB, among others. Furthermore, priming of the innate immune system by the microbiota may enhance the inflammatory response to cerebral amyloids (such as amyloid-β and α-synuclein). This paper describes the specific molecular pathways of these cross-seeding and neuroinflammatory processes. Evolutionary conservation of proteins provides the opportunity for conserved sequences and structures to influence neurological disease through molecular mimicry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Age-related perturbations in the gut microbiome have emerged as crucial factors contributing to age-related pathological conditions, including chronic inflammation,178 neurodegeneration,179 cognitive decline,180 and type 1 and type 2 diabetes.181”
From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [179]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“PD is characterized by accumulation of aggregated and phosphorylated AS in Lewy bodies and Lewy neurites [24] [25] [26].”
BackgroundHost-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · cited 1×
“It is estimated that there are 10X more cells and 130X more DNA in the metagenome than in our own bodies [40] [41].”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Table 2 Agents inducing molecular mimicry REF Bacteria * [9] [44] [56] Animal viruses * [3] Plant viruses * [4] [5] [15] Amyloids proteins in food [50] [56] Bacteria that make amyloid proteins * * Xanthomonas axonopodis * Exogenous as well as endogenous (found in the microbiota).”
BackgroundApolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · cited 1×
“ApoE, as a lipid-handling gene, influences bile acid secretion in humans and mucin secretion in murine lung, and has immunomodulatory effects [112] [113] [114] [115].”
BackgroundGut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · cited 2×
“In particular, the importance of diversity of diet leading to diversity of the microbiota is a new concept, which is clinically important [45] [123].”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · cited 1×
“The production of anti-inflammatory Treg cells may be enhanced by addition of " rationally selected " Clostridia strains [75].”
BackgroundThe gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791 · cited 1×
“Proteins from gut bacteria may gain access to neurons in the myenteric plexus because of the sampling of gut contents by epithelial microfold (M) cells as well as dendritic cells which deliver antigens to immune cells in Peyer’s patches [58, 59].”
Background
Research works printed but not linked: 1
- [103]103. Holmes C (2013) Review: Systemic inflammation and Alzheimer's disease. Neuropathol Appl Neurobiol 39, 51-68.
Cited by
Items 101–200 of 338
Gadhave, K., Kumar, D., Uversky, V. N., & Giri, R. (2021) · Medicinal Research Reviews · doi:10.1002/med.21719 · Cited by 68
“Furthermore, bacterial amyloids might cross‐seed formation of cerebral amyloids (such as Aβ, tau protein, and α‐synuclein) and also can activate signaling pathways that lead to the nerve cell death and progression of AD.(422) Human gut microbiota is involved in the structural integrity of intestinal mucosa by producin…”
BackgroundPerioperative neurocognitive dysfunction: thinking from the gut?
Xu, X., Hu, Y., Yan, E., Zhan, G., Liu, C., & Yang, C. (2020) · Aging · doi:10.18632/aging.103738 · Cited by 78
“A large number of bacteria and fungi in the gut, such as Escherichia coli, Salmonella enterica, Salmonella typhimurium, Mycobacterium tuberculosis and Staphylococcus aureus, can secrete functional extracellular amyloid, LPS and other related proinflammatory pathogenic signals [76, 77], which increase the CNS and syste…”
BackgroundBifari, F., Ruocco, C., Decimo, I., Fumagalli, G. F., Valerio, A., & Nisoli, E. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0582-2 · Cited by 73
“The age-related changes of the gut microbiota have been found especially important in pathophysiological processes of the age-related disorders, such as frailty [128], neurodegeneration [129], cognitive decline [130], T2DM [131], and cardiovascular diseases [132, 133].”
BackgroundYahfoufi, N., Matar, C., & Ismail, N. (2020) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glaa006 · Cited by 68
“are further encountered in AD subjects (82).”
Białecka-Dębek, A., Granda, D., Szmidt, M. K., & Zielińska, D. (2021) · Nutrients · doi:10.3390/nu13082514 · Cited by 75
Liang, Y., Liu, C., Cheng, M., Geng, L., Li, J., Du, W., Song, M., Chen, N., Yeleen, T. A. N., Li, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14057 · Cited by 83
Potential Role of the Gut Microbiome in ALS: A Systematic Review
Wright, M. L., Fournier, C., Houser, M. C., Tansey, M., Glass, J., & Hertzberg, V. S. (2018) · Biological Research For Nursing · doi:10.1177/1099800418784202 · Cited by 65
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease
Sun, P., Su, L., Zhu, H., Li, X., Guo, Y., Du, X., Zhang, L., & Qin, C. (2021) · Microorganisms · doi:10.3390/microorganisms9112281 · Cited by 69
“energy metabolism and increased cellular degeneration [25], contributing to the pathological processes of assorted neurological diseases, particularly neurodegeneration [26,27].”
BackgroundSex and Gender Differences in Alzheimer’s Disease: Genetic, Hormonal, and Inflammation Impacts
Kolahchi, Z., Henkel, N., Eladawi, M. A., Villarreal, E. C., Kandimalla, P., Lundh, A., McCullumsmith, R. E., & Cuevas, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158485 · Cited by 71
“The cytokines may proceed to initiate immunogenic responses, the release of reactive oxygen species, and the signaling of NF-κ B, CD14, and toll-like receptor 2/1, all of which contribute to neurodegeneration [111,113].”
BackgroundFunctional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
Atlante, A., Amadoro, G., Bobba, A., & Latina, V. (2020) · Cells · doi:10.3390/cells9112347 · Cited by 72
Contribution of Gut Microbiota to Immunological Changes in Alzheimer’s Disease
van Olst, L., Roks, S. J. M., Kamermans, A., Verhaar, B. J. H., van der Geest, A. M., Muller, M., van der Flier, W. M., & de Vries, H. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683068 · Cited by 74
Giovannini, M. G., Lana, D., Traini, C., & Vannucchi, M. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112358 · Cited by 61
Microbiome Influence in the Pathogenesis of Prion and Alzheimer’s Diseases
D’Argenio, V., & Sarnataro, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194704 · Cited by 61
“Since it is known that Aβ fibrils pass through both gut and brain barriers [84–86], an intriguing hypothesis is that different bacteria in the gut may produce amyloid fibers that are able to activate the immune system and, thus, trigger the typical AD brain neuroinflammation [87].”
BackgroundInteraction between food antigens and the immune system: Association with autoimmune disorders
Vojdani, A., Gushgari, L. R., & Vojdani, E. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102459 · Cited by 65
Liu, M., Guo, H. W., Li, Z., Zhang, C., Zhang, X., Cui, Q., & Tian, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.601603 · Cited by 61
“Other factors are also reported as a driving force in the genesis and development of AD, such as the long-term infections of bacteria and viruses (Bearer and Wu, 2019; Dominy et al., 2019), and the dyshomeostasis of intestinal flora (Friedland, 2015).”
BackgroundFriedland, R. P., McMillan, J. D., & Kurlawala, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051652 · Cited by 56
“Gut bacteria have been shown to remarkably influence microglial function [17] and bacterial amyloid is recognized by the innate immune system as a pathogen associated molecular pattern (PAMP) involving toll-like receptor 2 (TLR2), cluster of differentiation 14 (CD14), nuclear factor kappa light chain enhancer of activ…”
BackgroundSelf-citationGut microbiota produces biofilm-associated amyloids with potential for neurodegeneration
Fernández-Calvet, A., Matilla-Cuenca, L., Izco, M., Navarro, S., Serrano, M., Ventura, S., Blesa, J., Herráiz, M., Alkorta‐Aranburu, G., Galera, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48309-x · Cited by 60
“…amyloids can be considered as canonical molecular mimics of human molecules that can play a pathological role in the central nervous system (CNS) in certain situations, either by nucleating the polymerization of human amyloid proteins (cross-seeding) or priming an in fl am-matory response 47,49,73 .”
Ceppa, F., Izzo, L., Sardelli, L., Raimondi, I., Tunesi, M., Albani, D., & Giordano, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00297 · Cited by 60
“For this reason, preventative measures must include dental care as an intervention from an early age (Friedland, 2015).”
BackgroundWang, J., Ye, F., Cheng, X., Zhang, X., Liu, F., Liu, G., Ni, M., Qiao, S., Zhou, W., & Zhang, Y. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160138 · Cited by 52
“…proteins produced by Proteobacteria , Bacteriodetes , Chlo-roflexi , Actinobacteria , and Firmicutes [10, 11] may induce or influence AD through protein misfolding, induction of neuroinflammation and oxidative stress [2], enhancing colonization, adhesion to surfaces and biofilm development [10, 11].”
Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease
van Kessel, S. P., & El Aidy, S. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191780 · Cited by 52
“258 Molecular mimicry by extracellular amyloid pro259 teins produced by bacteria have been proposed as 260 one potential trigger inducing misfolding of neuronal 261 proteins via cross-seeding [63].”
BackgroundBacterial Extracellular DNA Promotes β-Amyloid Aggregation
Tetz, G. V., & Tetz, V. (2021) · Microorganisms · doi:10.3390/microorganisms9061301 · Cited by 52
“Although the molecular basis for Aβ aggregation has been extensively studied and accumulating evidence supports the notion that a prion-like mechanism is responsible for this process, until now, the exact factor responsible for triggering seeded nucleation remained elusive (14, 47).”
BackgroundEmerging Roles of Functional Bacterial Amyloids in Gene Regulation, Toxicity, and Immunomodulation
Salinas, N., Povolotsky, T. L., Landau, M., & Kolodkin‐Gal, I. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00062-20 · Cited by 59
“agents (168), raising concerns regarding the exposure of humans to various food”
BackgroundZhong, S.-R., Kuang, Q., Zhang, F., Chen, B., & Zhong, Z.-G. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0206 · Cited by 59
“In addition, curli cross-seedingwith Aβwas also observed, indicating that amyloid cross-seeding may be mediating AD pathology [109].”
BackgroundNutrition and Alzheimer Disease
Fernández, S. S. M., & Ribeiro, S. M. L. (2018) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2018.06.012 · Cited by 56
Szandruk-Bender, M., Wiatrak, B., & Szeląg, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133704 · Cited by 58
“Microbiota-derived amyloid proteins may act as prion proteins via molecular mimicry and elicit cross-seeding, in which one amyloidogenic protein (tau, Aβ, α-syn, curli, prion) provokes another to adopt a pathogenic β-sheet structure [48,49].”
BackgroundImplications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine
Javed, I., Cui, X., Wang, X., Mortimer, M., Andrikopoulos, N. K., Li, Y., Davis, T. P., Zhao, Y., Ke, P. C., & Chen, C. (2020) · ACS Nano · doi:10.1021/acsnano.0c07258 · Cited by 48
Microbial sensing in the intestine
Wan, T., Wang, Y., He, K., & Zhu, S. (2023) · Protein & Cell · doi:10.1093/procel/pwad028 · Cited by 51
Soriano, S., Curry, K. D., Wang, Q., Chow, E., Treangen, T. J., & Villapol, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094476 · Cited by 44
Merino del Portillo, M., Clemente-Suárez, V. J., Ruisoto, P., Jimenez, M., Ramos-Campo, D. J., Beltran-Velasco, A. I., Martínez-Guardado, I., Rubio-Zarapuz, A., Navarro-Jiménez, E., & Tornero-Aguilera, J. F. (2024) · Metabolites · doi:10.3390/metabo14100549 · Cited by 44
“Furthermore, the gut–brain axis plays a major role in the pathogenesis of many neurodegenerative disorders, including Alzheimer’s disease [106,118,151], Parkinson’s disease [107,113,137,142], amyotrophic lateral sclerosis, multiple sclerosis, and Huntington’s disease (HD) [152].”
BackgroundRaval, U., Harary, J. M., Zeng, E., & Pasinetti, G. M. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1775585 · Cited by 45
When the infectious environment meets the AD brain
Ganz, T., Fainstein, N., & Ben-Hur, T. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00559-3 · Cited by 39
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Borrego-Ruiz, A., & Borrego, J. J. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112497 · Cited by 47
Microbial signatures and therapeutic strategies in neurodegenerative diseases
Rob, M., Yousef, M., Lakshmanan, A. P., Mahboob, A., Terranegra, A., & Châari, A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117905 · Cited by 47
Saksida, T., Koprivica, I., Vujičić, M., Stošić‐Grujičić, S., Perović, M., Kanazir, S., & Stojanović, I. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170538 · Cited by 40
Computational analysis of candidate prion-like proteins in bacteria and their role
Iglesias, V., de Groot, N. S., & Ventura, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01123 · Cited by 39
“Moreover, it has been observed that bacterial amyloids can initiate the formation of amyloid aggregates upon interaction with diverse host proteins (Otzen and Nielsen, 2008; Hufnagel et al., 2013; Friedland, 2015; Hill and Lukiw, 2015).”
BackgroundAlzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link
Hu, J., & Wang, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.811852 · Cited by 49
“…can break the gut barrier into blood stream, finally enter the brain through the leaky blood–brainbarrier (or via olfactory bulb), where they prime residential microglia through molecular mimicry (Friedland, 2015) and promote neuroinflammation, neural injury, and ultimately neurodegeneration.”
BackgroundGut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
Li, J., Li, D., Chen, Y., Chen, W., Xu, J., & Gao, L. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s414714 · Cited by 40
“relationship between gut protein and cognitive ability has attracted much attention, indicating that amyloid protein can be produced by bacteria and increase α-synuclein pathology in vasectomised older rats.(272,273) It is undeniable that there are”
The critical role of gut-brain axis microbiome in mental disorders
Basiji, K., Sendani, A. A., Ghavami, S. B., Farmani, M., Kazemifard, N., Sadeghi, A., Lotfali, E., & Aghdaei, H. A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01248-w · Cited by 58
“CNS and bacterial amyloids share similarities in their tertiary structure however, they have a difference in their primary structure (Zhao et al. 2015 ; Friedland 2015 ).”
BackgroundSchlegel, P., Novotný, M., Klímová, B., & Vališ, M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190460 · Cited by 41
“Since higher levels of antibodies to periodontitis-causing bacteria have been found in serum in AD patients, another possible theory for entry of microorganisms into the CNS pathway is through the olfactory bulb [34, 35, 99].”
Doroszkiewicz, J., Mroczko, J., Winkel, I., & Mroczko, B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175057 · Cited by 41
“This process is known as cross-seeding, wherein one amyloidogenic protein (such as tau, A β , α -syn, curli, or prion) induces another to take on a pathological β -sheet structure [125,126].”
BackgroundTan, L. Y., Yeo, X. Y., Bae, H., Lee, D. P. S., Ho, R., Kim, J. E., Jo, D., & Jung, S. (2021) · Life · doi:10.3390/life11070698 · Cited by 36
Is There Any Link between Cognitive Impairment and Gut Microbiota? A Systematic Review
Angoorani, P., Ejtahed, H., Siadat, S. D., Sharifi, F., & Larijani, B. A. (2022) · Gerontology · doi:10.1159/000522381 · Cited by 43
Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones
Wu, Y., Hang, Z., Tong, L., & Du, H. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03784-w · Cited by 35
“Although the primary structure of gut-derived Aβ protein is different from that of brain Aβ protein, its tertiary structure is very similar, so gut-derived Aβ protein may trigger a cross-immune response and trigger the excessive activation of pro-inflammatory signaling pathways in the brain [46].”
BackgroundAquilani, R., Ramusino, M. C., Maestri, R., Iadarola, P., Boselli, M., Perini, G., Boschi, F., Dossena, M., Bellini, A., Buonocore, D., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1237469 · Cited by 36
“Translocated intestinal bacteria, bacterial amyloid, and toxins may increase brain inflammation, favoring the development of insulin resistance (Bhattacharjee and Lukiw, 2013; Friedland, 2015; Zhao et al., 2015; Aquilani et al., 2022).”
BackgroundPretorius, L., Kell, D. B., & Pretorius, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00851 · Cited by 36
“The molecular mimicry theory (Ebringer and Rashid, 2009; Proal et al., 2013, 2017) includes microbial curli fibers2 and Aβ as a protein–protein interaction which could result in cross-seeding, even if these proteins are essentially unalike (Friedland, 2015; Zhao et al., 2015).”
BackgroundScassellati, C., Galoforo, A. C., Esposito, C., Ciani, M., Ricevuti, G., & Bonvicini, C. (2021) · Aging and Disease · doi:10.14336/ad.2021.0122 · Cited by 37
“For instance, Friedland, 2015 [73] reported that AD patients showed higher profile of gram-negative bacteria, which cause a disruption of the mucosal barrier, as well as produce amyloid β-bacteria (Bacillus subtilis, Klebsiella pneumonia, Mycobacterium spp., Streptococcus spp.).”
BackgroundTarutani, S., Omori, M., Ido, Y., Yano, M., Komatsu, T., & Okamura, T. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.01.059 · Cited by 37
Bashir, Y., & Khan, A. U. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1030694 · Cited by 38
“…degeneration, lowgrade inflammation, increased oxidative stress, and perturbed energy metabolism (Noble et al., 2017), contributing to the progression of many neuropsychiatric, neurological, and neurodevelopmental conditions, especially neurodegeneration (Friedland, 2015; Mulak and Bonaz, 2015).”
BackgroundInfluentialOpportunities in pharmacogenomics for the treatment of Alzheimer’s disease
Cacabelos, R., Torrellas, C., & Carrera, I. (2015) · Future Neurology · doi:10.2217/fnl.15.12 · Cited by 33
Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective
Dong, S., Sun, M., He, C. H., & Cheng, H. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.02.015 · Cited by 34
Marć, M. A., Jastrząb, R., & Mytych, J. (2022) · Nutrients · doi:10.3390/nu14193967 · Cited by 36
“Increased production of Aβ-amyloid plaques Increased overall Aβ-amyloid plaques deposits Disruption of proteostasis via molecular mimicry mechanism [95]”
BackgroundCan Microbiota Research Change Our Understanding of Neurodegenerative diseases?
Scheperjans, F. (2016) · Neurodegenerative Disease Management · doi:10.2217/nmt-2015-0012 · Cited by 34
The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines
Cianci, R., Franza, L., Massaro, M. G., Borriello, R., Vito, F., & Gambassi, G. (2020) · Vaccines · doi:10.3390/vaccines8040636 · Cited by 32
Zhang, L., Yang, C., Li, Y., Niu, S., Liang, X., Zhang, Z., Luo, Q., & Luo, H. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.723317 · Cited by 33
“…Bacillus subtilis, Shigella, Escherichia coli, Salmonella enterica, Staphylococcus aureus, and Mycobacterium tuberculosis can produce functional extracellular amyloid proteins but not for Aβ42 peptides (Hufnagel et al., 2013; Schwartz and Boles, 2013; Friedland, 2015; Pistollato et al., 2016).”
BackgroundLupăescu, A.-V., Iavorschi, M., & Covașă, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020235 · Cited by 33
“In addition, exposure to bacterial amyloid may influence the immune system, thereby altering brain Aβ homeostasis by enhancing inflammatory responses to endogenous neuronal amyloids [13].”
BackgroundZhao, T., Zhong, S., Xu, J., Jiao, W., Liu, W., Huang, L., Zhang, Y., & Zhang, Y. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c06726 · Cited by 31
Dasriya, V. L., Samtiya, M., Dhewa, T., Puniya, M., Kumar, S., Ranveer, S. A., Chaudhary, V., Vij, S., Behare, P. V., Singh, N., et al. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.14043 · Cited by 30
Gut microbiota, pathogenic proteins and neurodegenerative diseases
Wei, W., Wang, S., Xu, C., Zhou, X., Lian, X., He, L., & Li, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.959856 · Cited by 33
“GM have been shown to produce amyloid, lipopolysaccharide (LPS), or other biological substances that disrupt intestinal homeostasis, affect the central nervous system through the MGB axis, and mediate the pathological process of NDs, such as inflammation, amyloid, and Tau protein accumulation in the brain (Friedland,…”
BackgroundDrosophila as a Model for Microbiota Studies of Neurodegeneration
Kitani‐Morii, F., Friedland, R. P., Yoshida, H., & Mizuno, T. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215031 · Cited by 31
Self-citationKarczewski, J., Zielińska, A., Staszewski, R., Eder, P., Dobrowolska, A., & Souto, E. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116145 · Cited by 26
Suman, P. R., Souza, L. S., Kincheski, G. C., Melo, H. M., Machado, M. N., Carvalho, G. M. C., Felice, F. G. D., Zin, W. A., & Ferreira, S. T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02662-0 · Cited by 30
“Gut microbiota has also been implicated in brain–periphery crosstalk [10].”
BackgroundManipulation of the diet–microbiota–brain axis in Alzheimer’s disease
Lee, D. D., Lee, V. M. ‐., & Hur, S. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1042865 · Cited by 29
“Other than contributions to the autoimmune process, it has been hypothesized that bacterial amyloids may indirectly induce the aggregation of human amyloidogenic proteins (Friedland, 2015; Chen et al., 2016; Miraglia and Colla, 2019).”
BackgroundTowards early detection of neurodegenerative diseases: A gut feeling
Makdissi, S., Parsons, B., & Cara, F. D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1087091 · Cited by 30
“Although bacterial amyloids differ from CNS amyloids in their primary structure, they share similarities in their tertiary structure (Friedland, 2015; Zhao et al., 2015).”
BackgroundMicrobial amyloids in neurodegenerative amyloid diseases
Sampson, T. R. (2023) · FEBS Journal · doi:10.1111/febs.17023 · Cited by 28
“It may be that microbial amyloids serve as mimics and such auto autoimmune responses due to structural similarities in conjunction with environmental contexts [143 – 145].”
The Use of Probiotic Therapy in Metabolic and Neurological Diseases
Lee, S. H. F., Ahmad, S. R., Lim, Y. C., & Zulkipli, I. N. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.887019 · Cited by 28
Intermittent Fasting on Neurologic Diseases: Potential Role of Gut Microbiota
Guo, M., Wang, X., Li, Y., Luo, A., Zhao, Y., Luo, X., & Li, S. (2023) · Nutrients · doi:10.3390/nu15234915 · Cited by 28
“Furthermore, it has been claimed thatthese factors may have an impact on the formation or aggregation of amyloid proteins [130,132–135].”
BackgroundVojdani, A., Vojdani, E., Saidara, E., & Kharrazian, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170961 · Cited by 25
“He hypothesized that molecular mimicry can be expanded beyond amino acid similarity identity to include micro-RNA and proteomic effect, which, in regard to AD and Parkinson’s disease, are either pathogenic or beneficial [32, 33].”
InfluentialEffects of gut microbiota and probiotics on Alzheimer’s disease
Guo, L., Xu, J., Du, Y., Wu, W., Nie, W., Zhang, D., Luo, Y., Lu, H., Lei, M., Xiao, S., et al. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0203 · Cited by 29
“Bacterial amyloid proteins are also found to promote misfolding and aggregation of neuronal Aβ peptides through cross-seeding [30,34,35].”
BackgroundZhu, H., Zhang, H., Hou, B., Xu, B., Ji, L., & Wu, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/9110560 · Cited by 29
“Dysbiosis of the gut microbiota and increased intestinal permeability overstimulate the immune system, leading to a neuroinfammatory response [8].”
BackgroundWu, Y., Niu, X., Li, P., Tong, T., Wang, Q., Zhang, M., Li, Y., Liu, J., & Li, Z. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03466-3 · Cited by 29
“Interestingly, it has been hypothesized that functional amyloid released from the gut microbiome spreads in a prion-like manner, which triggers the misfolding of neuronal proteins via cross seeding, priming innate immunity, and activating neuroinflammation (Kesika et al. 2021; Zhao et al.2019; McDonald et al 2016; Fri…”
BackgroundPatil, R. S., & Tupe, R. S. (2023) · Medicinal Research Reviews · doi:10.1002/med.21987 · Cited by 26
“341 The analysis of blood and CSF from AD patients showed inclined inflammatory events.”
BackgroundKulkarni, R., Kumari, S., Dhapola, R., Sharma, P., Singh, S. K., Medhi, B., & HariKrishnaReddy, D. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04545-2 · Cited by 29
“The primary amyloids produced by the gut microbiota are different from CNS amyloids, but the tertiary form is identical to that of CNS amyloids [73].”
Wang, C., & Zheng, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.875349 · Cited by 24
“The idea that amyloid proteins produced by the gut bacteria may cross-seed endogenous proteins, such as Aβ and α-synuclein, to promote neurodegeneration has been hypothesized before (Friedland, 2015) and independently validated in multiple ND models in recent studies.”
ResultCombination Therapy in Alzheimer’s Disease: Is It Time?
Salehipour, A., Bagheri, M., Sabahi, M., Dolatshahi, M., & Boche, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215680 · Cited by 22
“Particular diets and nutrients can impact the gut microbiota and alter its composition [114, 115], leading to increased bacteria-produced amy-loids and thus contributing to the onset of AD as described below [113, 116–118].”
A future perspective on neurodegenerative diseases: nasopharyngeal and gut microbiota
Khan, F., & Oloketuyi, S. F. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13327 · Cited by 23
“This may mimic bacterial infection causing glial cell activation through toll-like receptors as well as eliciting inflammation, cross-seeded misfolding and oxidative stress in the development of neurodegenerative diseases (Beraud and Maguire-Zeiss 2012; Friedland 2015; Mulak and Bonaz 2015).”
BackgroundEmery, D. C., Davies, M., Cerajewska, T. L., Taylor, J., Hazell, M., Paterson, A. R., Allen, S. J., & West, N. X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1026260 · Cited by 27
“, 2002) may act directly by prion-like propagation of protein pathology (Friedland, 2015; Friedland and Chapman, 2017).”
BackgroundLim, F. T., Lim, S. M., & Ramasamy, K. (2017) · Food & Function · doi:10.1039/c7fo00764g · Cited by 25
Small intestinal bacterial overgrowth in Alzheimer’s disease
Kowalski, K., & Mulak, A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02440-x · Cited by 24
“Through molecular mimicry bacterial amyloids may act as prion proteins that induce misfolding of native amyloids leading to their aggregation and deposition in amyloid plaques (Friedland 2015).”
BackgroundYuan, Z., Zhang, C., Peng, X., Shu, L., Long, C., & Tan, Z. (2020) · 3 Biotech · doi:10.1007/s13205-020-02172-x · Cited by 22
The Gut Microbiome and Alzheimer’s Disease: A Growing Relationship
Zerdan, M. B., Hebbo, E., Hijazi, A., Gemayel, M. E., Nasr, J., Nasr, D., Yaghi, M., Bouferraa, Y., & Nagarajan, A. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666221227090125 · Cited by 24
Welcome, M. O. (2018) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000492491 · Cited by 22
Wei, C., Wu, X., Li, C., Zhang, Y., Yuan, Q., & Huang, R. (2025) · The FASEB Journal · doi:10.1096/fj.202402572r · Cited by 20
“9,10 Evidence suggests that amyloid may function as an antimicrobial peptide within the brain.”
Gastrointestinal Changes and Alzheimer's Disease
Sohrabi, M., Sahu, B., Kaur, H., Hasler, W. A., Prakash, A. K., & Combs, C. K. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220617121255 · Cited by 19
Structural Mimicry in Microbial and Antimicrobial Amyloids
Golan, N., Engelberg, Y., & Landau, M. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-105157 · Cited by 20
Probiotics for Preventing Cognitive Impairment in Alzheimer’s Disease
Wong, C. B., Kobayashi, Y., & Xiao, J. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.79088 · Cited by 22
“and other microbial exudates into their circumjacent environment [44].”
BackgroundMicrobial Metabolomes in Alzheimer’s Disease: From Pathogenesis to Therapeutic Potential
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090724 · Cited by 22
“While microbial amyloids share only tertiary structural similarities with human CNS amyloids, they act as prion-like agents through molecular mimicry, inducing pathogenic β -sheet conformations in host amyloidogenic proteins [16,84–87].”
Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries
Nguyen, M. T., & Palm, N. W. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00948-2 · Cited by 21
“The accumulation of α-synuclein aggregates in gut vagal endings often precedes CNS symptoms in progressive Parkinson’s disease, and recent studies have shown that α-synuclein aggregates injected into the gut can transit to the brain via the vagus nerve [108] (Fig.”
BackgroundHuman gut microbiota and Parkinson's disease
Pant, A., Bisht, K. S., Aggarwal, S., & Maiti, T. K. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.08.004 · Cited by 18
Polyphenolic Compounds: Orchestrating Intestinal Microbiota Harmony during Aging
Pereira, Q. C., Fortunato, I. M., Oliveira, F. D. S., Alvarez, M. C., dos Santos, T. W., & Ribeiro, M. L. (2024) · Nutrients · doi:10.3390/nu16071066 · Cited by 19
“Additionally, there are neurofibrillary tangles composed of hyper-phosphorylated tau protein found in the cerebral cortex and other brain regions [66,67].”
BackgroundExploring the effect of gut microbiome on Alzheimer's disease
Pourahmad, R., Saleki, K., Zare, M., Aram, C., Farsani, A. S., Banazadeh, M., & Tafakhori, A. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101776 · Cited by 28
“The main structure of bacteria-produced amyloids differs from that of CNS amyloids, although their tertiary structure is similar [94].”
BackgroundA review on gut microbiota and miRNA crosstalk: implications for Alzheimer’s disease
Ayyanar, M. P., & Vijayan, M. (2024) · GeroScience · doi:10.1007/s11357-024-01432-5 · Cited by 25
“Emerging evidence reveals that dietary patterns and nutrients influence gut microbiota diversity [480] and may impact Aβ protein production or aggregation [481, 482].”
Young at Gut—Turning Back the Clock with the Gut Microbiome
Narasimhan, H., Ren, C. C., Deshpande, S., & Sylvia, K. E. (2021) · Microorganisms · doi:10.3390/microorganisms9030555 · Cited by 17
“Bacterial amyloid proteins also bear significant structural similarity to human Aβ, potentially inducing an immune response against self-antigens via molecular mimicry [55].”
BackgroundBeg, A. Z., Farhat, N., & Khan, A. U. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104982 · Cited by 19
Bacterial biofilm functionalization through Bap amyloid engineering
Matilla-Cuenca, L., Taglialegna, A., Gil, C., Toledo‐Arana, A., Lasa, Í., & Valle, J. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00324-w · Cited by 21
Effects of Qi-Fu-Yin on aging of APP/PS1 transgenic mice by regulating the intestinal microbiome
Xiao, Q., Ye, T., Wang, X., Qi, D., & Cheng, X. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1048513 · Cited by 18
“For example, intestinal bacteria affect the regulation of the immune system, thus altering the interaction between the immune system and the nervous system (Friedland, 2015; Solas et al., 2017).”
BackgroundA review of the roles of pathogens in Alzheimer’s disease
Zhao, M., Wang, Y., Shen, Y., Wei, C., Zhang, G., & Sun, L. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1439055 · Cited by 19
“By imitating the host’s molecular structures, pathogens can evade immune system recognition and clearance, allowing them to persist and continuously trigger pathological responses (Oldstone, 1998; Friedland, 2015).”
BackgroundLai, Y., Dhingra, R., Zhang, Z., Ball, L. M., Zylka, M. J., & Lü, K. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00656 · Cited by 23
The endocannabinoid system: a bridge between alzheimer’s disease and gut microbiota
Bisogno, T., Lauritano, A., & Piscitelli, F. (2021) · Life · doi:10.3390/life11090934 · Cited by 16
Yang, J., Deng, Y., Cai, Y., Liu, Y., Peng, L., Luo, Z., & Li, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1048565 · Cited by 18
“Priming of the innate immune system by the microbiota may enhance the inflammatory response to cerebral amyloids (such as amyloidbeta and alpha-synuclein), leading to neuro-system-related diseases such as Parkinson’s disease and Alzheimer’s disease (Friedland, 2015).”
BackgroundThe role of the gut microbiota in neurodegenerative diseases targeting metabolism
Fu, Y., Gu, Z., Cao, H., Zuo, C., Huang, Y., Song, Y., Jiang, Y., & Wang, F. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1432659 · Cited by 18
“…share tertiary structural similarities with neural amyloid (Friedland and Chapman, 2017), and through molecular mimicry, bacterial amyloid proteins can induce amyloid misfolding like prion proteins, leading to their aggregation and precipitation (Friedland and Chapman, 2017; Friedland, 2015).”
Background
Metadata
- Authors
- Friedland, R. P.
- Affiliations
- University of Louisville (US)
- Corresponding author
- Friedland, Robert P.
- ORCID
- Friedland, Robert P.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2015-03-18
- Volume
- 45
- Issue
- 2
- Pages
- 349-362
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1526611045
- Cited by
- 338
- References
- 129
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 31 · 2023: 30 · 2022: 52 · 2021: 49 · 2020: 35 · 2019: 25 · 2018: 24 · 2017: 24 · 2016: 13 · 2015: 10
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- University of Louisville
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- molecular mimicry, gut microbiota
- MeSH terms
- Animals, Humans, Cytokines, Molecular Mimicry, Neurodegenerative Diseases, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.